Abstract
Caspase 8 is a cysteine protease regulated in both a death-receptor-dependent and -independent manner during apoptosis. Here, we report that the gene for caspase 8 is frequently inactivated in neuroblastoma, a childhood tumor of the peripheral nervous system. The gene is silenced through DNA methylation as well as through gene deletion. Complete inactivation of CASP8 occurred almost exclusively in neuroblastomas with amplification of the oncogene MYCN. Caspase 8-null neuroblastoma cells were resistant to death receptor- and doxorubicin-mediated apoptosis, deficits that were corrected by programmed expression of the enzyme. Thus, caspase 8 acts as a tumor suppressor in neuroblastomas with amplification of MYCN.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Medema, J.P. et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794 –2804 (1997).
Fulda, S., Lutz, W., Schwab, M. & Debatin, K.M. Myc-N sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene 18, 1479–1486 (1999).
Brodeur, G.M. et al. Neuroblastoma. Cancer 70, 1685–1694 (1992).
Beltinger, C.P., White, P.S., Sulman, E.P., Maris, J.M. & Brodeur, G.M. No CDKN2 mutations in neuroblastoma . Cancer Res. 55, 2053– 2055 (1995).
Easton, J., Wei, T., Lahti, J.M. & Kidd, V.J. Disruption of the cyclin D/cyclin-dependent kinase/INK4/pRb regulatory pathway in human neuroblastoma . Cancer Res. 58, 2624– 2632 (1998).
Hueber, A.O. et al. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis. Science 278, 1305– 1309 (1997).
Grenet, J., Teitz, T., Wei, T., Valentine, V. & Kidd, V.J. Structure and chromosome localization of the human CASP8 gene. Gene 226, 225– 232 (1999).
Kohno, Y., Morishita, K., Takano, H., Shapiro, D.N. & Yokota, J. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene 9, 103– 108 (1994).
Rasper, D.M. et al. Cell death attenuation by ‘Usurpin’, a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Diff. 5, 271–288 (1998).
Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 ( 1992).
Askew, D.S., Ashmun, R.A., Simmons, B.C. & Cleveland, J.L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915–1922 ( 1991).
Harrington, E.A., Bennett, M.R., Fanidi, A. & Evan, G.I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines . EMBO J. 13, 3286–3295 (1994).
Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. & Issa, P. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141–196 (1998).
Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1, 686–692 ( 1995).
Whang, Y.E. et al. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad. Sci. USA 95, 5246–5250 ( 1998).
Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826 ( 1996).
Soengas, M.S. et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156– 159 (1999).
Grenet, J. et al. Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma. Genomics 49 , 385–393 (1998).
Kitson, J. et al. A death-domain-containing receptor that mediates apoptosis . Nature 384, 372–375 (1996).
Muzio, M. et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85, 817–827 ( 1996).
Yeh, W.C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954–1958 (1998).
Varfolomeev, E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267– 276 (1998).
Friesen, C., Herr, I., Krammer, P.H. & Debatin, K.-M. Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2, 574– 577 (1996).
Fulda, S., Sieverts, H., Friesen, C., Herr, I. & Debatin, K-M. The CD95 system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57, 3823–3829 (1997).
Eischen, C.M. et al. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions . Blood 90, 935–943 (1997).
Landowski, T.H. et al. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation. Blood 94, 265– 274 (1999).
Juin, P., Hueber, A.O., Littlewood, T. & Evan, G.I. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13, 1367– 1381 (1999).
Zornig, M., Grzeschiczek, A., Kowalski, M.B., Hartmann, K.U. & Moroy, T. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in Eμ L-MYC transgenic mice but not in animals infected with MoMuLV. Oncogene 10, 2397– 2401 (1995).
Rehemtulla, A., Hamilton, C.A., Chinnaiyan, A.M. & Dixit, V.M. Ultraviolet radiation-induced apoptosis is mediated by activation of CD95 (Fas/APO-1). J. Biol. Chem. 272, 25783– 25786 (1997).
White, P.S. et al. A region of consistent deletion in neuroblastoma maps within 1p36.2-.3. Proc. Natl. Acad. Sci. USA 92, 5520–5524 (1995).
Cheng, N.C. et al. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10, 291–297 (1995).
Tang, D., et al. Caspase-8 activation and Bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis . J. Biol. Chem. 275, 9303– 9307 (2000).
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T. & van der Bruggen, P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186 , 785–793 (1997).
Corn, P.G. et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res. 59, 3352–3356 (1999).
Scaffidi, C., Medema, J.P., Krammer, P.H. & Peter, M.E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/α and caspase-8/β. J.Biol.Chem. 272, 26953–26958 (1997).
Parra, I. & Windle, B. High resolution visual mapping of stretched DNA by fluorescent hybridization. Nature Gen. 5, 17–21 (1993).
Gururajan, R. et al. Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2. Genome Res. 8, 929–939 ( 1998).
Cheng, J. et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759– 1761 (1994).
Chinnaiyan, A.M., O'Rourke, K., Tewari, M. & Dixit, V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505– 512 (1995).
Persons, D.A. et al. Enforced expression of the GATA-2 transcriptional factor blocks normal hematopoiesis. Blood 93, 488– 499 (1999).
Tang, D., Lahti, J.M., Grenet, J. & Kidd, V.J. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism . J. Biol.Chem. 274, 7245– 7252 (1999).
Milligan, C. E. et al. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15, 385–393 ( 1995).
Janicke, R.U., Lee, F.H.H. & Porter, A.G. Nuclear c-myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol. 14, 5661–5670 ( 1994).
Acknowledgements
The authors thank S. Slabaugh, Y.Y. Ling and S. Rowe for technical assistance and J. Cleveland for comments and suggestions regarding the manuscript. We acknowledge the Hartwell Center for Bioinformatics and Biotechnology (St. Jude Children's Research Hospital) and C. Naeve for oligonucleotide synthesis and DNA sequence analysis. This research was supported by National Institutes of Health grants CA 67938, CA71907, a Cancer Center Core grant from the National Institutes of Health to St. Jude Children's Research Hospital (CA 21765), and by support from the American Lebanese Syrian Associated Charities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teitz, T., Wei, T., Valentine, M. et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6, 529–535 (2000). https://doi.org/10.1038/75007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/75007
This article is cited by
-
Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging
Nature Communications (2024)
-
Rubiarbonol B induces RIPK1-dependent necroptosis via NOX1-derived ROS production
Cell Biology and Toxicology (2023)
-
Comparative epigenomics by machine learning approach for neuroblastoma
BMC Genomics (2022)
-
The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference
Cell Death & Disease (2022)
-
Neuroblastoma and the epigenome
Cancer and Metastasis Reviews (2021)